[HTML][HTML] The 35th anniversary of the discovery of EPR effect: a new wave of nanomedicines for tumor-targeted drug delivery—personal remarks and future prospects

H Maeda - Journal of personalized medicine, 2021 - mdpi.com
This Special Issue on the enhanced permeability and retention (EPR) effect commemorates
the 35th anniversary of its discovery, the original 1986 Matsumura and Maeda finding being …

The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

J Fang, H Nakamura, H Maeda - Advanced drug delivery reviews, 2011 - Elsevier
The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid
tumors related to their anatomical and pathophysiological differences from normal tissues …

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

H Maeda - Advanced drug delivery reviews, 2015 - Elsevier
The enhanced permeability and retention (EPR) effect of solid tumors as seen with
nanomedicines and macromolecular drugs is well known. However, many researchers …

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

J Fang, W Islam, H Maeda - Advanced drug delivery reviews, 2020 - Elsevier
The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid
tumors that is related to their particular anatomical and pathophysiological characteristics …

Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting

H Maeda - Proceedings of the Japan Academy, Series B, 2012 - jstage.jst.go.jp
Tumor and inflammation have many common features. One hallmark of both is enhanced
vascular permeability, which is mediated by various factors including bradykinin, nitric oxide …

Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls

H Nakamura, F Jun, H Maeda - Expert opinion on drug delivery, 2015 - Taylor & Francis
Introduction: A major problem with conventional antitumor therapeutics is nonselective
delivery of cytotoxic drugs to normal vital organs and tissues but little delivery to tumor …

The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives

R Sun, J Xiang, Q Zhou, Y Piao, J Tang, S Shao… - Advanced Drug Delivery …, 2022 - Elsevier
Over the past three decades, the enhanced permeability and retention (EPR) effect has
been considered the basis of tumor-targeted drug delivery. Various cancer nanomedicines …

Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines

K Greish - Journal of drug targeting, 2007 - Taylor & Francis
Over the past two decades cancer has ascended the causes of human death to be number
one or two in many nations world wide. A major limitation inherent to most conventional …

[HTML][HTML] The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy

Y Shi, R van der Meel, X Chen, T Lammers - Theranostics, 2020 - ncbi.nlm.nih.gov
Following its discovery more than 30 years ago, the enhanced permeability and retention
(EPR) effect has become the guiding principle for cancer nanomedicine development. Over …

Factors affecting the dynamics and heterogeneity of the EPR effect: Pathophysiological and pathoanatomic features, drug formulations and physicochemical factors

R Islam, H Maeda, J Fang - Expert opinion on drug delivery, 2022 - Taylor & Francis
Introduction The enhanced permeability and retention (EPR) effect serves as the foundation
of anticancer nanomedicine design. EPR effect-based drug delivery is an effective strategy …